Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. | Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. | The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested. | The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.
Cain Wettan Keeley M
EVP Gen Counsel, Legal & Comp·Direct
Tax W/H · Dispose
Common Stock
Shares-283
Price$121.48
Total Value$34.4K
Shares Owned After5.36K
Transaction DateJun 10, 2026
Cain Wettan Keeley M
EVP Gen Counsel, Legal & Comp·Direct
Exercise · Acquire
Common Stock
Shares+589
Price-
Total Value$0
Shares Owned After5.64K
Transaction DateJun 10, 2026
Footnotes ▸
Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
Post-Transaction Holdings
Cain Wettan Keeley M
Security
Shares
Change
Common Stock
5.36K
+306 (6.05%)
Restricted Stock Unit
20.00K
-589 (-2.86%)
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership ===
Document Type: 4
Period of Report: 2026-06-10
10b5-1 Pre-arranged Plan: No
--- Issuer ---
Name: GILEAD SCIENCES, INC. (GILD)
CIK: 0000882095
--- Reporting Owner ---
Name: Cain Wettan Keeley M
CIK: 0002110603
Role: Officer (EVP Gen Counsel, Legal & Comp)
--- Non-Derivative Transactions ---
[Transaction #1]
Security: Common Stock
Date: 2026-06-10 | Code: M (Exercise of derivative)
Shares: +589
Shares Owned After: 5,643 | Ownership: D (Direct)
Footnotes:
[F1] Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
[Transaction #2]
Security: Common Stock
Date: 2026-06-10 | Code: F (Payment of exercise/tax)
Shares: -283 | Price: $121.48
Total Value: $34,378.84
Shares Owned After: 5,360 | Ownership: D (Direct)
--- Derivative Transactions ---
[Transaction #1]
Security: Restricted Stock Unit
Date: 2026-06-10 | Code: M (Exercise of derivative)
Shares: -589
Shares Owned After: 19,997 | Ownership: D (Direct)
Footnotes:
[F1] Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
[F1] Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
[F2] The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.
[F2] The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.
--- Footnotes (Complete Index) ---
F1: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
F2: The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.
--- Signature ---
/s/ /s/ Amy Kim by Power of Attorney for Keeley M. Cain Wettan (2026-06-11)
